| For: | Li J, Wang M, Zhang B, Wu X, Lin TL, Liu XF, Zhou Y, Zhang XH, Xu H, Shen LJ, Zou J, Lu P, Zhang D, Gu WJ, Zhang MX, Pan J, Cao H, Chinese Society of Surgeons for Gastrointestinal Stromal Tumor of the Chinese Medical Doctor Association. Chinese consensus on management of tyrosine kinase inhibitor-associated side effects in gastrointestinal stromal tumors. World J Gastroenterol 2018; 24(46): 5189-5202 [PMID: 30581268 DOI: 10.3748/wjg.v24.i46.5189] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v24/i46/5189.htm |
| Number | Citing Articles |
| 1 |
Xuehui Jiang, Qun Fu, Ying Kong, Hong Liu, Kaisaner Rexiti, Hongwei Peng, Pin Xiao, Xiaohua Wei. Gene Polymorphisms Affect Postoperative Imatinib Plasma Levels and Edema in Adults With Gastrointestinal Stromal Tumor. Pharmacogenomics 2023; 24(7) doi: 10.2217/pgs-2022-0171
|
| 2 |
Hao Xu, Qi Liu. Individualized Management of Blood Concentration in Patients with Gastrointestinal Stromal Tumors. OncoTargets and Therapy 2021; doi: 10.2147/OTT.S279998
|
| 3 |
Xuehui Jiang, Fangfang Xiong, Qun Fu, Hongwei Peng, Yan Jing, Kaisaner Rexiti, Xiaohua Wei, Song Tao. Hematologic toxicities of sunitinib in patients with gastrointestinal stromal tumors: a systematic review and meta-analysis. International Journal of Colorectal Disease 2022; 37(7) doi: 10.1007/s00384-022-04214-7
|
| 4 |
Jennifer S. Downs, David E. Gyorki. Perioperative Care of the Cancer Patient. 2023; doi: 10.1016/B978-0-323-69584-8.00030-X
|
| 5 |
俊昱 李. Progress and Current Status of Diagnosis and Treatment of Gastrointestinal Stromal Tumor. Advances in Clinical Medicine 2025; 15(08) doi: 10.12677/acm.2025.1582291
|
| 6 |
Jian Wang, Yuan Yin, Chaoyong Shen, Xiaonan Yin, Zhaolun Cai, Lin Pu, Wei Fu, Yaxuan Wang, Bo Zhang. Preoperative imatinib treatment in patients with locally advanced and metastatic/recurrent gastrointestinal stromal tumors. Medicine 2020; 99(9) doi: 10.1097/MD.0000000000019275
|
| 7 |
Qiang Zhang, Fengyuan Li, Feng Wang, Yongjian Zhou, Haoran Qian, Ming Wang, Xin Wu, Ye Zhou, Linsen Zhou, Luning Sun, Yongqing Wang, Zekuan Xu, Xiaofeng Sun, Hao Xu. Monitoring the plasma concentration of ripretinib and its metabolites in Chinese patients with gastrointestinal stromal tumors in a real‐life setting. Cancer 2025; 131(S3) doi: 10.1002/cncr.70149
|
| 8 |
Xiao Huang, Linhua Chen, Li Liu, Hefen Chen, Zhujun Gong, Jianbo Lyu, Yao Li, Qi Jiang, Xiangyu Zeng, Peng Zhang, Hong Zhou. Untargeted metabolomics analysis reveals the potential mechanism of imatinib-induced skin rash in patients with gastrointestinal stromal tumor. International Immunopharmacology 2024; 140 doi: 10.1016/j.intimp.2024.112728
|
| 9 |
Ryo Fujiwara, Takeshi yuasa, kenichi kobayashi, tetsuya yoshida, susumu kageyama. Pembrolizumab plus lenvatinib for radically unresectable or metastatic renal cell carcinoma in the Japanese population. Expert Review of Anticancer Therapy 2023; 23(5) doi: 10.1080/14737140.2023.2200170
|
| 10 |
Yongzhou Huang, Xiangyu Zeng, Ye Zhou. Clinical Management of Gastrointestinal Stromal Tumor. 2024; doi: 10.1007/978-981-99-9392-5_14
|
| 11 |
Xinhua Zhang, Yulong He, Yingjiang Ye. Updates on research and management of gastrointestinal stromal tumors in China. Cancer 2025; 131(S3) doi: 10.1002/cncr.70155
|
| 12 |
Alan L. Myers, Sudarat Kiat-amnuay, Bing-Yan Wang. Effect of imatinib on oral wound healing after extraction. The Journal of the American Dental Association 2022; 153(8) doi: 10.1016/j.adaj.2022.03.009
|
| 13 |
Michał Miner, Michał Elbaum, Aleksandra Jawiarczyk-Przybyłowska, Eliza Kubicka. Endokrynologiczne powikłania nowych terapii przeciwnowotworowych. Postępy Higieny i Medycyny Doświadczalnej 2021; 75(1) doi: 10.5604/01.3001.0014.8121
|
| 14 |
Yanglu Ou, Pan Ran, Qijuan Zhang, Jun Zhang, Juan Li. Investigation of Nutritional Status by GLIM Criteria in Outpatients with GIST. Nutrition and Cancer 2025; 77(7-8) doi: 10.1080/01635581.2025.2512621
|
| 15 |
Bo Ni, Jian Li, Lin Shen. Clinical Management of Gastrointestinal Stromal Tumor. 2024; doi: 10.1007/978-981-99-9392-5_26
|
| 16 |
Xiaoman Liu, Mengying Pi, Mukai Chen, Shirong Cai, Yulong He, Ke-Jing Tang, Xinhua Zhang, Yanzhe Xia. The management of imatinib-associated severe skin rash in gastrointestinal stromal tumor: desensitization therapy and pharmacogenetic investigation. The Oncologist 2025; 30(7) doi: 10.1093/oncolo/oyaf176
|